Employee turnover continues to impact the global market for talent in Clinical Research Organizations. The companies that will be successful in not only retaining top talent but also in recruiting will employ innovative approaches to their reward strategies.
This Insights Report is based on results from the recently published BDO CRO Industry Global Compensation & Turnover Survey. This Insights Report discusses how now, more than ever, companies are digging deep to find ways to make sure employees stay, which is stirring the buzz term “The Great Retention.” A few key topics covered in this Insights Report include:
BDO’s annual CRO Industry Global Compensation & Turnover Survey collects data for 268 positions in the US and 55 countries outside of the US. This survey is designed to help clinical research outsourcing companies develop confidence in their pay levels by providing data necessary to gain insight into their compensation practices relative to the market.
Download the report here.
2022/2023 Clinical Research Organization Compensation & Turnover Insights Report. (2023, January 24). BDO.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.